Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension
W Xu, FT Kaneko, S Zheng, SAA Comhair… - The FASEB …, 2004 - Wiley Online Library
Pulmonary arterial hypertension (PAH), a fatal disease of unknown etiology characterized by
impaired regulation of pulmonary hemodynamics and vascular growth, is associated with …
impaired regulation of pulmonary hemodynamics and vascular growth, is associated with …
[引用][C] Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension
W Xu, FT Kaneko, S Zheng, SAA Comhair… - The FASEB …, 2004 - cir.nii.ac.jp
Increased arginase II and decreased NO synthesis in endothelial cells of patients with
pulmonary arterial hypertension | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
pulmonary arterial hypertension | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
[PDF][PDF] Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension
W Xu, FT Kaneko, S Zheng, SAA Comhair, AJ Janocha… - 2004 - researchgate.net
Pulmonary arterial hypertension (PAH), a fatal disease of unknown etiology characterized by
impaired regulation of pulmonary hemodynamics and vascular growth, is associated with …
impaired regulation of pulmonary hemodynamics and vascular growth, is associated with …
Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension
W Xu, FT Kaneko, S Zheng… - … publication of the …, 2004 - pubmed.ncbi.nlm.nih.gov
Pulmonary arterial hypertension (PAH), a fatal disease of unknown etiology characterized by
impaired regulation of pulmonary hemodynamics and vascular growth, is associated with …
impaired regulation of pulmonary hemodynamics and vascular growth, is associated with …
[PDF][PDF] Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension
W Xu, FT Kaneko, S Zheng, SAA Comhair, AJ Janocha… - 2004 - academia.edu
Pulmonary arterial hypertension (PAH), a fatal disease of unknown etiology characterized by
impaired regulation of pulmonary hemodynamics and vascular growth, is associated with …
impaired regulation of pulmonary hemodynamics and vascular growth, is associated with …
Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension.
W Xu, SAA Comhair, AJ Janocha, T Goggans… - FASEB …, 2004 - search.ebscohost.com
Deals with a study which evaluated the expression of nitric oxide synthase (NOS) and the
factors that regulate NOS activity in patients with pulmonary arterial hypertension (PAH) …
factors that regulate NOS activity in patients with pulmonary arterial hypertension (PAH) …
Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension.
W Xu, FT Kaneko, S Zheng, SA Comhair… - … : Official Publication of …, 2004 - europepmc.org
Pulmonary arterial hypertension (PAH), a fatal disease of unknown etiology characterized by
impaired regulation of pulmonary hemodynamics and vascular growth, is associated with …
impaired regulation of pulmonary hemodynamics and vascular growth, is associated with …
[引用][C] Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension
W XU - FASEB J., 2004 - cir.nii.ac.jp
Increased arginase II and decreased NO synthesis in endothelial cells of patients with
pulmonary arterial hypertension | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
pulmonary arterial hypertension | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …